Medoflyukon capsules are used at the following indications:

• sharp vaginal candidiasis when local therapy is not reasonable;
• a candidosis balanitis when local therapy is not reasonable.

Structure

Active ingredient - flukonazol (one capsule supports a flukonazol of 150 mg).

Excipients: lactose, monohydrate; starch corn prezhelatinizirovanny; silicon dioxide colloidal waterless, sodium lauryl sulfate; magnesium stearate; are a part of the capsule: patent blue V (E 131), titan dioxide (E 171), gelatin.

Contraindication

• hypersensitivity to a flukonazol, other azolny connections or to any of medicine excipients;
• simultaneous application of a flukonazol and terfenadin to patients who apply flukonazol repeatedly in doses 400 mg/days and above (according to results of a research of interaction of repeated application);
simultaneous application of a flukonazol and other medicines which extend an interval of QT and are metabolized by
• by means of CYP2A4 enzyme (for example a tsizaprida, an astemizola, Pimozidum, quinidine, Amiodaronum and erythromycin).

Route of administration

should swallow of

Capsule entirely. Administration of medicament does not depend on meal.

Adult: medicament is used inside in a dose of 150 mg once.

Pregnant

Observation researches showed to

Feature of application

increased risk of spontaneous abortion at the women receiving flukonazol during the first trimester of pregnancy. Researches on animals of reproductive toxicity. It is not necessary to apply usual doses of a flukonazol and short-term courses of treatment flukonazoly during pregnancy, except for need. It is not necessary to apply high doses of a flukonazol and/or long courses of treatment flukonazoly during pregnancy, except for treatment of infections which potentially threaten life.

Flukonazol is found out in breast milk in the concentration close to plasma therefore its appointment is not recommended to women in the period of a lactation. Breastfeeding is possible after single application of a standard dose of a flukonazol of 200 mg or smaller. Breastfeeding is not recommended at repeated application or application of high doses of a flukonazol.

Research on animals men's and female were not shown by influences of a flukonazol on fertility.

Children Efficiency and safety of use of medicine for treatment of genital candidiases at ​​ children are not established to

by

, despite exhaustive data on use of medicine for children. If there is an urgent need of use of medicine to children (aged from 12 up to 17 years), it is necessary to apply usual doses to adults.

Drivers

did not carry out

Researches of influence of a flukonazol on ability to steer motor transport or other mechanisms. Patsiyentov it is necessary to inform on a possibility of development of dizziness or spasms at application of a flukonazol. At development of such symptoms it is not recommended to steer motor transport or to work with other mechanisms.

by

Overdose

received the message about overdose flukonazoly; it was at the same time reported about hallucinations and paranoid behavior.

needs to carry out by

At overdose symptomatic maintenance therapy and if necessary to wash out a stomach.

Flukonazol is substantially brought by

with urine; the artificial diuresis can accelerate medicine removal. The session of a hemodialysis lasting 3 hours reduces the level of a flukonazol in blood plasma by 50%.

Side effects

Most frequent side reactions (> 1/10) are the headache, an abdominal pain, diarrhea, nausea, vomiting, rash, increase in level of alaninaminotranspherase (ALT), aspartate aminotransferase (ACT) and alkaline phosphatase of blood.

Storage conditions

to Store

in original packing at a temperature not above 25 °C, out of children's reach.

Expiration date - 4 years.